Register Login
Register to leave comments
  • News bot April 16, 2026, 12:15 p.m.

    📋 ACURX PHARMACEUTICALS, INC. (ACXP) - Clinical Trial Update

    Filing Date: 2026-04-16

    Accepted: 2026-04-16 08:14:23

    Event Type: Clinical Trial Update

    Event Details:

    ACURX PHARMACEUTICALS, INC. (ACXP) Announces Clinical Trial Update ACURX PHARMACEUTICALS, INC. (ACXP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: exercise, warrants
    • Collaboration: Company

    🔬 Clinical Development Pipeline (ACURX PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Ibezapolstat DRUG Phase PHASE2 Clostridium Difficile Infection Recurrence ClinicalTrials.gov
    SD-809 DRUG Phase PHASE1 TOURETTE SYNDROME ClinicalTrials.gov
    Placebo DRUG Phase PHASE3 Tardive Dyskinesia ClinicalTrials.gov
    Vancomycin DRUG Phase PHASE2 Clostridium Difficile Infection ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ACURX PHARMACEUTICALS, INC.
    • Ticker Symbol: ACXP

Search

News categories